COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,196 Articles (22,713 medRxiv, 8,483 bioRxiv)

Most recent first Previous |  Page 211: Articles 2101-2110  | Next

Structural and functional analyses of SARS-CoV-2 Nsp3 and its specific interactions with the 5' UTR of the viral genome
Lemak, S., Skarina, T., Flick, R., Patel, D. T., Stogios, P. J., Savchenko, A.
10.1101/2024.05.09.593331 — Posted: 2024-05-09
Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domain
Guerra, D., Radic, L., Brinkkemper, M., Poniman, M., van der Maas, L., Torres, J. L., Ward, A. B., Sliepen, K., Schinkel, J., Sanders, R. W., van Gils, M. J., Beaumont, T.
10.1101/2024.05.09.593284 — Posted: 2024-05-09
The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism: An interrupted time-series analysis in England using OpenSAFELY-TPP
Cunningham, C., Macdonald, O., Schaffer, A. L., Brown, A. D., Wiedemann, M., Fisher, L., Curtis, H. J., Mehrkar, A., Higgins, R., Hulme, W. J., Speed, V., Ward, T., Croker, R., Walker, A. J., Butler-Cole, B., Andrews, C. D., Parry, J., Bates, C., Evans, D., Inglesby, P., Dillingham, I., Davy, S., Bridges, L., O'Dwyer, T., Maude, S., Smith, R., Hart, L., Goldacre, B., Bacon, S., MacKenna, B.
10.1101/2024.05.08.24306990 — Posted: 2024-05-08
Novel Deep CNNs Explore Regions, Boundaries, and Residual Learning for COVID-19 Infection Analysis in Lung CT
Khan, S. H.
10.1101/2024.05.08.24307035 — Posted: 2024-05-08
Rapid spread of the SARS-CoV-2 Omicron XDR lineage derived from recombination between XBB and BA.2.86 subvariants circulating in Brazil in late 2023
Arantes, I., Ito, K., Gomes, M. F. C., de Carvalho, F. C., de Almeida, W. A. F., Khouri, R., Miyajima, F., Wallau, G., Naveca, F. G., Pereira, E. C., COVID-19 Fiocruz Genomic Surveillance Network, , Siqueira, M. M., Resende, P. C., Bello, G.
10.1101/2024.05.07.24306998 — Posted: 2024-05-08
Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Non-structural Proteins Inhibitors
Lu, X., Hu, H., Mei, L., Wang, X., Xiong, L., Zhu, Y., Liu, S., Zhao, W., Mengnisa, S., Li, L., Lin, X., Liu, J., Wang, X., Duan, Z., Lu, W., Suo, Y., Wu, X., Cui, M., Yue, J., Xu, Y.
10.1101/2024.05.08.593105 — Posted: 2024-05-08
TMEM106B-mediated SARS-CoV-2 infection allows for robust ACE2-independent infection in vitro but not in vivo
Yan, K., Dumenil, T., Stewart, R., Bishop, C. R., Tang, B., Suhrbier, A., Rawle, D. J.
10.1101/2024.05.08.593110 — Posted: 2024-05-08
Genomic epidemiology of early SARS-CoV-2 transmission dynamics in Bangladesh
Carnegie, L., McCrone, J., Du Plessis, L., Hasan, M., Ali, M. Z., Begum, R., Hassan, M. Z., Islam, S., Rahman, M. H., Uddin, A., Sarker, M. S., Das, T., Hossain, M. M., Khan, M., Razu, M. H., Akram, A., Arina, S., Hoque, M. E., Molla, M. M. A., Nafisa, T., Angra, P., Rambaut, A., Pullan, S., Osman, K., Hoque, M. A., Biswas, P., Flora, M. S., Raghwani, J., Fournie, G., Samad, M. A., Hill, S. C.
10.1101/2024.05.07.24306987 — Posted: 2024-05-07
Mexicos surge of violence and COVID 19 drive life expectancy losses 2015 2021.
Zazueta-Borboa, J. D., Vazquez Castillo, P., Gargiulo, M., Aburto, J. M.
10.1101/2024.05.07.24306982 — Posted: 2024-05-07
Immunogenicity and Safety of Gamma, Omicron BA.4/5 and Bivalent SARS-CoV-2 RBD-based Protein Booster Vaccines in Adults Previously Immunized with Different Vaccine Platforms: a Phase II/III, Randomized, Clinical Trial.
Perez-Marc, G., Coria, L. M., Ceballos, A., Rodriguez, J. M., Lombardo, M. E., Bruno, L., Paez Cordoba, F., Fascetto Cassero, C. G., Salvatori, M., Rios Medrano, M. A., Fulgenzi, F. R., Alzogaray, M. F., Mykietiuk, A., Uriarte, I. L., Itcovici, N., Smith Casabella, T. E., Corral, G., Bruno, M. E., Roldan, O., Nunez, S. A., Cahn, F., Bianchi, A., Braem, V. M., Christmann, A., Corradetti, S., Darraidou, M. C., Di Nunzio, L., Estrada, T. B., Lopez Castelo, R., Marchionatti, C. G., Pitocco, L., Trias Uriarte, V. M., Wood, C. J., Zadoff, R., Bues, F., Garrido, R. M., Laboratorio Pablo Cassara group
10.1101/2024.05.06.24306575 — Posted: 2024-05-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).